Ana I. Kuehne

United States Army Medical Research Institute of Infectious Diseases — United States

Medicine · Health Sciences

28h-index4.5kcitations69works4.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Viral Infections and Outbreaks Research(58), Viral Infections and Vectors(42), Mosquito-borne diseases and control(14), Viral gastroenteritis research and epidemiology(14), SARS-CoV-2 and COVID-19 Research(13)

Publications69 total

Characterization of a STAT-1 Knockout Mouse Model for Machupo Virus Infection and Pathogenesis
Viruses·2025Open Access
Avidity and variable domain spacing strongly influence the therapeutic potency of bispecific antibodies against Crimean-Congo hemorrhagic fever virus
mBio·2025Open Access
Antibodies targeting Crimean-Congo hemorrhagic fever virus GP38 limit vascular leak and viral spread
Science Translational Medicine·2025· 7 citedOpen Access
Engineering and structures of Crimean-Congo hemorrhagic fever virus glycoprotein complexes
Cell·2024· 8 citedOpen Access
Longitudinal proteome-wide antibody profiling in Marburg virus survivors identifies wing domain immunogen for vaccine design
Nature Communications·2024· 3 citedOpen Access
A Longitudinal Analysis of Memory Immune Responses in Convalescent Crimean-Congo Hemorrhagic Fever Survivors in Uganda
The Journal of Infectious Diseases·2024· 4 cited
Crimean-Congo hemorrhagic fever survivors elicit protective non-neutralizing antibodies that target 11 overlapping regions on glycoprotein GP38
Cell Reports·2024· 10 citedOpen Access
Antibodies targeting Crimean-Congo hemorrhagic fever virus GP38 limit vascular leak and viral spread
2024· 3 citedOpen Access
Engineering, structure, and immunogenicity of a Crimean–Congo hemorrhagic fever virus pre-fusion heterotrimeric glycoprotein complex
2024· 2 citedOpen Access
Design and characterization of protective pan-ebolavirus and pan-filovirus bispecific antibodies
PLoS Pathogens·2024· 3 citedOpen Access
Crimean-Congo Hemorrhagic Fever Survivors Elicit Protective Non-Neutralizing Antibodies that Target 11 Overlapping Regions on Viral Glycoprotein GP38
2024· 4 citedOpen Access
Long-term Sudan Virus Ebola Survivors Maintain Multiple Antiviral Defense Mechanisms
The Journal of Infectious Diseases·2023· 4 cited
Author Correction: Two point mutations in protocadherin-1 disrupt hantavirus recognition and afford protection against lethal infection
Nature Communications·2023Open Access
Two point mutations in protocadherin-1 disrupt hantavirus recognition and afford protection against lethal infection
Nature Communications·2023· 4 citedOpen Access
Prophylactic Administration of the Monoclonal Antibody Adintrevimab Protects against SARS-CoV-2 in Hamster and Non-Human Primate Models of COVID-19
Antimicrobial Agents and Chemotherapy·2022· 2 citedOpen Access
1143. Prophylactic and Therapeutic Activity of AZD7442 (Tixagevimab/Cilgavimab) in SARS-CoV-2 Hamster Challenge Models
Open Forum Infectious Diseases·2022Open Access
Two point mutations in protocadherin-1 disrupt Andes hantavirus recognition and afford protection against lethal infection
2022Open Access
The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humans
Science Translational Medicine·2022· 208 citedOpen Access
Two Distinct Lysosomal Targeting Strategies Afford Trojan Horse Antibodies With Pan-Filovirus Activity
Frontiers in Immunology·2021· 12 citedOpen Access
AZD7442 demonstrates prophylactic and therapeutic efficacy in non-human primates and extended half-life in humans
2021· 12 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

John M. Dye(38), Kartik Chandran(19), Andrew S. Herbert(18), Russell R. Bakken(14), Julius J. Lutwama(13), Andrew S. Herbert(11), Leslie Lobel(11), Dafna M. Abelson(9), Spencer W. Stonier(8), Thijn R. Brummelkamp(7), Larry Zeitlin(7), Jason S. McLellan(7), Ariel Sobarzo(7), Stephanie R. Monticelli(7), Samantha E. Zak(6), Anna Z. Wec(6), Albert Wang(6), Sean P. J. Whelan(5), Ariel S. Wirchnianski(5), Rohit K. Jangra(5)